One of the pillars of Iran's pharmaceutical industry with a history of nearly half a century of continuous activity
The largest manufacturer of cardiovascular drugs in the country
The first manufacturer of ready-to-inject enoxaparin sodium syringes with the Enoxan brand in Iran
Advanced PFS production system and extensive export network
153 قلم داروی تولیدی
Has the largest and most equipped multi-storey warehouse in Iran
GMP certified for all lines
Received a silver statuette in the ۷th Excellence and Progress Award
History
Alborz Darou Pharmaceutical Company, one of the cornerstones of Iran’s pharmaceutical industry, with nearly half a century of continuous operation, is currently recognized as the country’s largest producer of cardiovascular medications.
Our journey began in 1976. After operating under various titles over the years, the company was officially established as “Alborz Darou” in 1984.
Throughout the decades, by advancing our technologies, improving infrastructure, and scaling up production capacity, Alborz Darou has played a pivotal role in supplying vital medications to the country.
Being ranked among the top five public pharmaceutical companies is the result of these years of dedication and an unwavering commitment to quality.
Management Statement
International Cooperation
Expanding partnerships with foreign companies for technology transfer and improving product quality.
Development of Export Markets
Active presence in regional and global markets and increasing the share of exports.
Focus on Profitable Products
Increase the share of high value-added products to improve financial efficiency.
Expanding the Product Portfolio
Adding new products based on emerging pharmaceutical market needs.
Enhancing GMP Standards
Improving infrastructure and processes to fully comply with international GMP requirements.
Strengthening Relationships with Stakeholders
Increasing effective interactions with employees, business partners, and regulatory authorities.
Guiding Principles of Alborz Darou Company
To create value for key stakeholders and contribute to sustainable development by promoting public health through the supply and development of high-quality human pharmaceutical products, formulations, and raw materials, while leveraging human capital and knowledge-based technologies in domestic and international markets
1- رعایت کرامت انسانی
2- اهتمام به دانش محوری و مشارکت جویی کارکنان
3- اهتمام به ایجاد و بهبود مستمر کیفیت، ارزش، خلاقیت و نوآوری در محصولات وخدمات
4- الویت در ایمنی و سلامت کارکنان وصیانت از منابع ملی و محیط زیست در عملیات و منابع
5- اعمال هوشمندی و تفکر اقتصادی در تصمیم گیری ها و تدابیر اجرایی
6- احترام متقابل و تعامل دو سویه با ذینفعان درون و برون سازمانی
7- احترام و رعایت ارزش های ملی ومذهبی در کلیه مناسبت های سازمانی
8- اهتمام به تقویت جایگاه سازمانی در جامعه
9- اهتمام در چابک سازی عملیات و فرآیندهای سازمان
Alborz Darou Company (Public Joint Stock Company), a subsidiary of Barkat Health and Pharmaceutical Group, is active in the development, supply, production, and distribution of high-quality human pharmaceutical products in various forms for consumers in domestic and international markets, aligned with patients’ needs in both prevention and treatment.
Export
شرکت البرزدارو با صادرات محصولات با کیفیت و قابل رقابت در بازارهای جهانی به کشورهای عراق، سوریه، پاکستان، افغانستان، اوگاندا، بلاروس، تاجیکستان و لبنان نام خود را طی 10 سال گذشته در عرصه بینالملل نمایان کرده است.